Celltrion Bags FDA Approval For High-Concentration Humira Rival

Yuflyma, Ninth US Adalimumab Biosimilar, Will Be Marketed Directly By Korean Firm

Red 100 emoji
Celltrion has obtained approval for a 100mg/ml adalimumab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products